Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR‐γ selective topical retinoid, in patients with moderate facial and truncal acne

BACKGROUND: Treatment for both facial and truncal acne has not sufficiently been studied. OBJECTIVES: To evaluate the long‐term safety and efficacy of trifarotene in both facial and truncal acne. METHODS: In a multicentre, open‐label, 52‐week study, patients with moderate facial and truncal acne rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Blume‐Peytavi, U., Fowler, J., Kemény, L., Draelos, Z., Cook‐Bolden, F., Dirschka, T., Eichenfield, L., Graeber, M., Ahmad, F., Alió Saenz, A., Rich, P., Tanghetti, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acne, Rosacea and Hidradenitis Suppurativa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004112/
https://www.ncbi.nlm.nih.gov/pubmed/31306527
http://dx.doi.org/10.1111/jdv.15794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004112/
https://www.ncbi.nlm.nih.gov/pubmed/31306527
http://dx.doi.org/10.1111/jdv.15794

Ejemplares similares